Currently out of the existing stock ratings of David Lewis, 133 are a BUY (49.26%), 124 are a HOLD (45.93%), 13 are a SELL (4.81%).

David Lewis

Work Performance Price Targets & Ratings Chart

Analyst David Lewis, carries an average stock price target met ratio of 82.7% that have a potential upside of 20.57% achieved within 340 days. Previously, David Lewis worked at MORGAN STANLEY.

David Lewis’s has documented 495 price targets and ratings displayed on 30 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on NTLA, Intellia Therapeutics at 04-Aug-2023.

Wall Street Analyst David Lewis

Analyst best performing recommendations are on SWAV (SHOCKWAVE MEDICAL).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 11/14/2016. The price target of $28 was fulfilled within 4 days with a profit of $3.18 (12.81%) receiving and performance score of 32.03.

Average potential price target upside

of $50.48 (16.46%) on ABMD (ABIOMED).
of $46.25 (29.59%) on SWAV (SHOCKWAVE MEDICAL).
of $44.87 (35.69%) on JNJ (JOHNSON & JOHNSON).

ABMD ABIOMED AXNX Axonics Modulation Technologies BAX Baxter International BDX Becton Dickinson and Company BSX Boston Scientific Corp DXCM DexCom HOLX Hologic HRC Hill-Rom Holdings IRT Independence Realty Trust ISRG Intuitive Surgical JNJ Johnson & Johnson MDT Medtronic PLC NVRO Nevro Corp PODD Insulet ZBH Zimmer Biomet Holdings EW Edwards Lifesciences Corp ABT Abbott Laboratories NARI Inari Medical SWAV Shockwave Medical HAE Haemonetics LUNG Pulmonx Corp SYK Stryker TMDX TransMedics Group NTLA Intellia Therapeutics IRTC iRhythm Technologies BVS Bioventus HR Healthcare Realty Trust TFX Teleflex VRA Vera Bradley VRAY ViewRay

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Cecilia Furlong